Patent · US Active

Pyrazole derivatives

US7767696B2 · kind B2 · utility

2Cited by

0References

5Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Guenter Hoelzemann · Seeheim-Jugenheim, DE
Helene Crassier · Darmstadt, DE
Wilfried Rautenberg · Reinheim, DE

Key dates

Filing date	Mar 8, 2006
Grant date	Aug 3, 2010
Priority date	—
Expiry date	Jun 26, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula (I), in which R1 and R2 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases, and can be employed, inter alia, for the treatment of tumours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.